Skip to main content
Essex Bio-Technology Limited logo

Essex Bio-Technology Limited — Investor Relations & Filings

Ticker · 1061 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2025-05-21 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 1061

About Essex Bio-Technology Limited

http://www.essexbio.com

Essex Bio-Technology Limited is a bio-pharmaceutical company specializing in the development, manufacture, and commercialization of genetically engineered therapeutic Fibroblast Growth Factors (FGFs), particularly recombinant bovine basic FGF (rb-bFGF). The company utilizes recombinant DNA technology to produce biologic drugs aimed at the treatment and healing of surface and organ wounds. Its portfolio includes six flagship biologics approved for a wide range of indications across key therapeutic areas: Ophthalmology, Dermatology, and Wound Healing. Leveraging an in-house R&D platform focused on growth factors and antibodies, the company maintains an active pipeline of projects. Its commercial reach extends to over 14,100 hospitals, supported by 46 regional sales offices.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 MAY 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an announcement of the poll results from the Annual General Meeting held on 21 May 2025, listing each resolution and the votes for and against. This corresponds exactly to Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-21 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly return (Form FF301) filed with the Hong Kong Stock Exchange detailing movements in authorized share capital, issued shares, share options and other equity-related items. It is not an annual report, earnings release, M&A announcement or any of the other defined categories. It is a regulatory compliance filing specific to the exchange’s listing rules, which does not neatly fit into share issue/financing (SHA) or transaction in own shares (POS) because it covers a broader set of equity movements and is a regular periodic return. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2025-05-02 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders advising them that the Company’s Annual Report for the year ended 31 December 2024 (along with other corporate communications) has been published online, and provides instructions to request printed copies. It does not contain the full Annual Report or other substantive financial content, but merely announces its availability and how to obtain it. This matches the definition of a Report Publication Announcement (RPA).
2025-04-03 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal “Notice of Annual General Meeting” setting out the date, venue, agenda items (ordinary and special resolutions) and proxy voting arrangements. It is clearly sent to shareholders to provide information and solicit votes on meeting resolutions rather than reporting financial results or presenting earnings. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2025-04-03 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF CORPORATE COMMUNICATIONS
Report Publication Announcement Classification · 1% confidence The document is a notification letter to shareholders informing them of the publication of the company’s annual report and related AGM circular (including notice of meeting and proxy form) on the HKEX and company websites, and providing instructions for obtaining printed copies. It does not contain the actual report or detailed financial content itself but serves solely as an announcement. According to the “menu vs meal” rule, this is a Report Publication Announcement.
2025-04-03 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 21 MAY 2025 (or any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a FORM OF PROXY for the upcoming Annual General Meeting of Essex Bio-Technology, detailing how shareholders may appoint proxies to vote on AGM resolutions (re-election of directors, dividend, share mandates, etc.). This is not the meeting notice itself, nor the AGM presentation, nor the vote results. It clearly falls under materials sent to shareholders to solicit proxy votes. Therefore, it is a Proxy Solicitation & Information Statement.
2025-04-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.